Markets:

Overview

News

Currencies

International

Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

6.716 +0.106 (+1.61%)

Streaming Delayed Price Updated: 3:12 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Champions Oncology (CSBR) Earnings Call Transcript ↗

Today 10:16 EST

Champions Oncology (CSBR) Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Champions Oncology (CSBR) Earnings Transcript ↗

Today 10:11 EST

Champions Oncology (CSBR) Earnings Transcript

Via The Motley Fool

Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗

December 15, 2025

Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins.

Via Chartmill

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

December 15, 2025

Via ACCESS Newswire

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025

December 08, 2025

Via ACCESS Newswire

Insights Ahead: Champions Oncology's Quarterly Earnings ↗

September 12, 2025

Via Benzinga

Champions Oncology Reports Record Annual Revenue of $57 Million

July 23, 2025

Via ACCESS Newswire

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

September 15, 2025

Via ACCESS Newswire

Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗

September 15, 2025

Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform.

Via Chartmill

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

September 15, 2025

Via ACCESS Newswire

Earnings Scheduled For September 15, 2025 ↗

September 15, 2025

Via Benzinga

Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025

September 10, 2025

Via ACCESS Newswire

Earnings Scheduled For July 23, 2025 ↗

July 23, 2025

Via Benzinga

Recap: Champions Oncology Q2 Earnings ↗

December 11, 2024

Via Benzinga

A Peek at Champions Oncology's Future Earnings ↗

December 10, 2024

Via Benzinga

4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗

September 03, 2025

Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.

Via Benzinga

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

July 21, 2025

Via ACCESS Newswire

Champions Oncology Announces Appointment of New CEO

July 18, 2025

Via ACCESS Newswire

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

July 08, 2025

Via ACCESS Newswire

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

April 28, 2025

Via ACCESS Newswire

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

April 24, 2025

Via ACCESS Newswire

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

March 11, 2025

Via ACCESS Newswire

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

March 06, 2025

Via ACCESS Newswire

Earnings Scheduled For March 11, 2025 ↗

March 11, 2025

Via Benzinga

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

February 18, 2025

Via ACCESS Newswire

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗

January 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 17, 2025

Via Benzinga

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

January 08, 2025

Via ACCESSWIRE

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

December 11, 2024

Via ACCESSWIRE

Earnings Scheduled For December 11, 2024 ↗

December 11, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.